安进公司称，由于在与阿斯利康合作开发银屑病药物的试验中发现自杀想法，将终止合作。 安进表示，对于这个后期临床试验药物 brodalumab，这样的安全问题可能会导致一个限制性标签，大大减少使用 b...
Amgen company said as found with AstraZeneca to cooperate in the development of psoriasis drug test in suicidal thoughts and will be terminated. Amgen said for the late stage clinical trials of drugs seen, such security problems may lead to a restrictive label, greatly reducing the use of B...
